Offer - Urjas Oil for just ₹ 1
Folitrax 7.5 Mg Injection, a prescription drug, is manufactured in various forms such as Injection. It is typically used for the treatment of Non-Hodgkin Lymphoma, Lymphoma. Folitrax 7.5 Mg Injection also has some secondary and off-label uses. These are listed below.
The correct dosage of Folitrax 7.5 Mg Injection depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Folitrax 7.5 Mg Injection also has some side effects, the most common being Abdominal Pain. While these are the most often observed Folitrax 7.5 Mg Injection side effects, there are can be others also. These have been listed below. Such side effects of Folitrax 7.5 Mg Injection normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Folitrax 7.5 Mg Injection's effect during pregnancy is Severe and Severe while nursing. Warnings related to Folitrax 7.5 Mg Injection's effects on the liver, heart and kidney, if any, have been listed below.
Folitrax 7.5 Mg Injection is contraindicated in people with pre-existing medical conditions like Infections, Liver Disease, Anemia as it can result in adverse effects. Some other conditions that can be affected by Folitrax 7.5 Mg Injection are listed in the contraindications section below.
Drug reaction of Folitrax 7.5 Mg Injection with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Folitrax 7.5 Mg Injection, it is important to know that it is safe while driving, and is habit-forming.
Folitrax 7.5 Mg Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Folitrax 7.5 Mg Injection safe for pregnant women?
Folitrax shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Folitrax 7.5 Mg Injection safe during breastfeeding?
Folitrax should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Folitrax 7.5 Mg Injection on the Kidneys?
There may be some adverse effects on kidney after taking Folitrax. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Folitrax 7.5 Mg Injection on the Liver?
Folitrax may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Folitrax 7.5 Mg Injection on the Heart?
Side effects of Folitrax rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Folitrax 7.5 Mg Injection unless your doctor advises you to do so -
Is this Folitrax 7.5 Mg Injection habit forming or addictive?
Folitrax 7.5 Mg Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Folitrax 7.5 Mg Injection since it does not cause drowsiness.
Is it safe?
Folitrax 7.5 Mg Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Folitrax 7.5 Mg Injection cannot treat any kind of mental disorder.
Interaction between Food and Folitrax 7.5 Mg Injection
There is no information on the effects of taking Folitrax 7.5 Mg Injection with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Folitrax 7.5 Mg Injection
Chances of side effects of drinking alcohol while taking Folitrax 7.5 Mg Injection are low. If you feel any adverse effects, please seek medical advice as soon as possible.
Folitrax contains methotrexate which is a chemotherapy drug that works in cancer by preventing the DNA synthesis of cancerous cells. It inhibits dihydrofolic acid reductase enzyme which is important for the formation of tetrahydrofolate. Tetrahydrofolate is essential for the synthesis of some DNA components of the cancerous cells. Incase of autoimmune and inflammatory diseases such as psoriasis, rheumatoid arthritis, and Crohn's disease Folitrax works by suppressing the body's normal immune response to inflammation. This results in reduced inflammation and provides relief from the symptoms associated with these diseases.
No, Folitrax is not a steroid. It is an antimetabolite (a chemotherapy drug) and disease-modifying antirheumatic drug (DMARDs) which have immunosuppressant properties. It is used in the treatment of various types of cancer and other diseases such as psoriasis, rheumatoid arthritis, and Crohn's disease.
No, Folitrax does not raise blood sugar levels (hyperglycemia). It has not been reported by the patients who are taking it. However, if you are experiencing increased thirst, trouble concentrating, and frequent urination which are symptoms of increased blood sugar levels (hyperglycemia) then do discuss with your doctor.
Take Folitrax as directed by your doctor. Do not take this medicine longer than prescribed to avoid unpleasant side effects.
Folitrax contains methotrexate (a chemotherapy) which is used in the treatment of various types of cancers. Nonetheless, it has been associated with an increased risk for melanoma, non-Hodgkin's lymphoma, and lung cancer.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methotrexate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 862-863
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 832-834
